Jessica Madera-McDonough, MD

  • 1Article
  • 9.9KReads
  • 2023Active
  • 7Collaborators
  • 12Citations

About

Jessica Madera-McDonough, MD is affiliated with Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, New Jersey. Jessica Madera-McDonough has contributed 1 peer-reviewed article published across the Journal of Clinical Psychiatry and the Primary Care Companion for CNS Disorders in 2023. Their work focuses on Schizophrenia/Schizoaffective Disorders.

Publications

JCP
Safety and Efficacy of Aripiprazole 2-Month Ready-to-Use 960 mg
Original Research

Safety and Efficacy of Aripiprazole 2-Month Ready-to-Use 960 mg

September 4, 2023

A new formulation of injectable aripiprazole for administration every 2 months showed similar rates of treatment-emergent adverse events to aripiprazole once-monthly 400 mg. Patients in both groups remained clinically...
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe